Biotechs Must Work With NIH To Tackle “Complexity,” NIH Director Tells BIO

Pharmaceutical and biotech companies need to work with NIH to put new research tools into the public domain, National Institutes of Health Director Elias Zerhouni, MD, told the recent Biotechnology Industry Organization investor conference in New York